Introduction
An AI tool to combat health insurance denials turns a dense refusal letter into a cited, policy-aware appeal that patients can file in minutes. Only about half of the 21 percent of privately insured adults who faced a coverage denial last year even bothered to appeal. Those numbers come from a Commonwealth Fund survey of 4,500 adults cited by Time in 2026. The newer generation of consumer tools wants to change that math by stripping away the time, legal fear, and paperwork drag that quietly kill most appeals. Platforms such as Counterforce Health, Claimable, and Fight Health Insurance read a denial letter and produce a cited letter grounded in plan terms, CPT codes, and clinical guidelines. For doctors stuck on hold with prior authorization, the same systems reduce preparation time from hours to minutes while raising success rates against insurer algorithms. For patients, the tools mean an appeal can realistically reach an insurer within one evening rather than one month. The ground war between patient AI and insurer AI is already shaping how care gets paid for in 2026.
Quick Answers on AI Tools That Fight Health Insurance Denials
What is an AI tool that fights health insurance denials?
It is software that reads a denial letter, matches it against plan language, statutes, and clinical guidelines, then drafts a cited appeal a patient or doctor can file. Leading examples include Counterforce Health, Claimable, and Fight Health Insurance.
Do AI appeal tools actually get denials reversed?
Counterforce Health reports a 75 percent approval rate on 10,000-plus appeals. Claimable reports roughly three in four user wins. Independent verification is limited, but reversals rise sharply when appeals are structured, cited, and timely.
Is it legal and private to use an AI tool to combat health insurance denials?
Yes, filing an AI-drafted appeal is legal nationwide, and reputable tools run on HIPAA-grade infrastructure with on-device OCR or signed business associate agreements. Patients should still review the letter and redact sensitive data.
Key Takeaways on Using AI Against Coverage Denials
- Only around half of denied claims are ever appealed, so an AI tool to combat health insurance denials wins first by simply making an appeal happen at all.
- Leading tools (Counterforce Health, Claimable, Fight Health Insurance) draft cited letters in roughly two minutes, down from a traditional two-week manual process.
- California SB 1120 now requires a licensed physician to sign off on medical-necessity denials, which opens a new procedural angle for AI appeals.
- The strongest AI appeals pair a patient’s denial with real plan language, clinical guidelines, and state insurance regulator precedents, then route the final letter through the ACA external review process.
Table of contents
- Introduction
- Quick Answers on AI Tools That Fight Health Insurance Denials
- Key Takeaways on Using AI Against Coverage Denials
- Understanding How AI Fights a Health Insurance Denial
- The Rising Tide of Denials AI Is Being Asked to Fix
- How an AI Appeal Tool Reads a Denial Letter
- Legal and Clinical Evidence These Tools Cite
- Comparing Leading AI Appeal Tools for Patients
- Clinic Implementation: How Doctors and Billing Teams Deploy AI Appeals
- Patient Workflow From Upload to Final Decision
- External Review and the ACA Safety Net
- Insurer AI Versus Patient AI in the Same System
- Ethical Lines AI Appeal Tools Must Not Cross
- Privacy, HIPAA, and Data Handling Realities
- Risks, Error Rates, and Hallucination Concerns
- Measurable Outcomes Patients Are Reporting
- Buying the Right AI Appeal Service in 2026
- State Laws Reshaping AI-Driven Utilization Review
- Future of AI Advocacy in American Healthcare
- Key Insights From Current Data
- Comparison Table: Leading AI Appeal Tools
- Real-World Examples of AI Appeals in Practice
- In-Depth Case Studies of Reversed Denials
- Frequently Asked Questions on AI Tools That Fight Health Insurance Denials
Understanding How AI Fights a Health Insurance Denial
An AI tool to combat health insurance denials reads a denial, matches it against plan language, statutes, and guidelines, and drafts a cited appeal. Patients or clinicians then file it with the insurer or an external reviewer.
Appeal Reversal Likelihood Estimator
Set your situation. The estimator mixes vendor-reported win rates, denial-reason weights, and state-law bonuses to show a rough chance of reversal with and without an AI tool to combat health insurance denials.
Not medically necessary
Other state
Marketplace
Counterforce Health
Baseline (no AI tool)
35 percent
Reversal odds if you file a standard letter without AI assistance.
With this AI tool
75 percent
Rough combined odds using the tool, your state, and the denial reason.
Estimates are heuristic. Baseline reversal weights informed by CMS external appeals data. Vendor lift from Counterforce Health vendor data and Time 2026. State-law bonus from SB 1120.
The Rising Tide of Denials AI Is Being Asked to Fix
Health insurance denials in the United States have climbed year over year, and each refusal lands on a patient already trying to recover. The Experian State of Claims Report 2026 surveyed 204 finance and billing leaders and found that 40 percent see at least one in ten claims denied. In that same study, 75 percent of providers said denials are rising, and 65 percent said clean claim submission is harder than a year ago. The scale of refusal is now large enough that denial management is its own profession, and AI is the obvious force multiplier. Patients feel the strain first, but clinicians and billing teams absorb the operational cost close behind.
Services not covered has quietly replaced coding errors as the top reason for refusals, per Experian, with 53 percent of respondents citing it among their top three denial drivers. Frequently changing payer policies came in at 31 percent, and coding errors tied with prior authorization at 25 percent each. Those four buckets map almost perfectly onto the arguments an AI-driven insurance denial pattern makes on both sides of the desk. A patient-side AI appeal tool needs to rebut exactly those four reasons. It cites plan language for coverage, policy history for sudden changes, correct codes for billing errors, and clinical guidelines for prior authorization denials.
Patient experience sharpens the numbers behind those denial drivers across private insurance plans. The Commonwealth Fund survey that Time summarized in November 2026 found 43 percent of denied patients took on medical debt. About half of those denial-driven debts topped one thousand dollars per account for the affected household. Only around half of denied adults even filed an appeal, which means the underlying reversal rate is masked by widespread attrition. Fewer than one in a hundred patients, by Counterforce Health’s accounting, pursues denials to external review. AI tools are being pitched less as magic bullets and more as a way to close that attrition gap.
Denial drag also tracks the demographics of who ends up with a refusal. ValuePenguin’s analysis of marketplace plans shows denial rates vary from under 5 percent to over 50 percent across insurers on HealthCare.gov. That variance makes patient advocacy a lottery, where the plan you picked at open enrollment often decides whether a prescription or MRI makes it through. Marketplace denials also disproportionately hit low-income enrollees and people with chronic conditions, who have the least bandwidth for appeal paperwork. An AI tool to combat health insurance denials therefore does not just reduce effort. It narrows the equity gap between patients who can afford a human advocate and those who cannot.
How an AI Appeal Tool Reads a Denial Letter
Building on that foundation, every reputable AI appeal tool starts with the denial letter itself. The quality of the letter it writes back depends on how carefully it parses that document. Fight Health Insurance uses on-device OCR to pull the denial reason, CPT codes, plan ID, member number, and statutory basis directly from the photo. It then matches them against its database of published state regulator decisions and peer-reviewed appeals. Counterforce Health asks for the denial letter plus a redacted copy of the plan document. It then cross-references the plan’s own exclusions, coverage carve-outs, and medical-necessity definitions against the stated reason for refusal. The difference between a weak appeal and a reversible one almost always lies in how specifically the drafter refers to the plan’s own language.
Many tools also pull in the patient’s clinical record, with explicit consent, so the appeal can cite the exact diagnosis code, ordering physician, and prior failed therapies. Claimable lets its users paste prior denials, provider notes, and prescription history into a structured template. It then feeds that evidence stack into a large language model grounded in insurance law, as described by PYMNTS in 2026. This structured intake is what lets AI appeal services route patients to the correct review path. The system can tell whether the denial hinges on medical necessity, coverage, or experimental-service grounds.
Legal and Clinical Evidence These Tools Cite
Shifting focus to evidence, the quality of citations is the single biggest predictor of whether an appeal lands. Reputable AI tools draw on three distinct evidence layers: the plan contract, applicable law, and clinical guidelines. Counterforce Health markets a training set of successful appeals and peer-reviewed clinical literature, including UpToDate, AMA guidelines, and NCCN pathways where available. Claimable’s publicly documented stack adds federal and state statutes, ERISA case law, and patient-protection rulings from state insurance regulators. Together those three layers give the AI letter a legal spine that insurers have to engage with, not brush aside.
The legal layer matters because denials usually fail on process, not medicine. Fight Health Insurance built its appeal arena on state regulator overturn decisions. If a California regulator reversed a denial for a similar drug in 2024, the tool can quote that precedent verbatim. Appeal letters that cite a plan’s own medical-necessity definition and then paste a clinical-guideline recommendation that satisfies it reverse at markedly higher rates than vague “please reconsider” letters. That is why the strongest tools lean on evidence hygiene and cite the actual URL of the guideline rather than a summary.
Clinical citations also matter when the denial hinges on experimental or investigational classifications. AI tools paired with evidence libraries can rebut an “experimental” label by citing FDA approval dates, peer-reviewed outcome studies, and inclusion in national cancer or endocrine society pathways. Patients who want a sense of how regulators weigh such claims can read the FDA regulation of AI health tools for context. In practice the strongest appeals weave plan language, statute, and clinical evidence into one short, cited argument that a human reviewer has to engage with on the merits. That multi-layered argument is exactly what AI appeal tools are purpose-built to produce quickly.
Comparing Leading AI Appeal Tools for Patients
Beyond individual features, comparing the leading AI appeal tools side by side helps patients pick the right fit. Counterforce Health positions itself as a nonprofit, free-for-patients platform founded in Durham, North Carolina in January 2025 and reported on Wikipedia to have piloted at Wilmington Health’s rheumatology clinic. Claimable, co-founded in 2023 by physician Warris Bokhari, charges around 50 dollars per case, covers 28 conditions and 90 treatments, and has raised 10 million dollars including from Mark Cuban. Fight Health Insurance stays completely free, uses on-device OCR, and offers a paid faxing option for users who do not want to print and mail. Two other services, Billyze and Mediloop, round out the market with billing-review and bill-negotiation angles rather than denial appeals.
Those three tools each handle a different kind of patient profile and appeal context. Counterforce suits patients who want a free, nonprofit option grounded in peer-reviewed clinical sources, with hands-on case management for complex cases. Claimable works well for patients with denials inside its 28 supported conditions who want a faster, more automated letter and are willing to pay for it. Fight Health Insurance appeals to privacy-focused patients who want to keep data on-device and submit the appeal themselves. No single tool dominates on every axis, so the right AI appeal platform depends on condition, budget, and comfort with paperwork.
Pricing is only the first screen that patients should look at when choosing. Patients should also check data-handling policies, whether the tool can route appeals through the correct internal and external review paths, and how the service handles complex multi-claim denials. Insurance and finance experts argue that clinics with high denial volume should also compare provider-side solutions that integrate directly with their revenue cycle systems. For a broader read on how insurers approach AI across the stack, our patient-facing primer on how insurers apply AI across the industry helps balance expectations. The right choice usually comes down to whether the patient wants speed, privacy, or hand-holding on complex multi-claim cases.
Clinic Implementation: How Doctors and Billing Teams Deploy AI Appeals
Turning to the clinician side, doctors and billing teams have embraced AI appeal tools faster than any other healthcare constituency, with implementation now reaching large multi-specialty practices. A physician at Wilmington Health told WECT that Counterforce cut appeal preparation time and raised success rates compared with manual letters. Counterforce’s own marketing claims a three to five times lift in revenue-cycle productivity, 80 percent lower appeal cost per case, and a five percent revenue recovery increase for adopting clinics. For an understaffed rheumatology or oncology practice, that is the difference between fighting every denial and triaging them. Specialty clinics in particular report a steep drop in appeal preparation time per case.
Clinic workflows typically integrate the appeal tool into the billing software’s denial queue. A denial lands in the billing team’s dashboard and triggers the AI appeal workflow immediately. The AI pre-drafts a cited appeal using the patient’s chart, and a human biller or nurse case manager reviews and edits before filing. Some practices now triage denials by expected success probability, directing scarce human attention to the hardest cases while letting the AI process straightforward ones. For a deeper view of how AI reshapes revenue cycle operations, an overview of AI reshaping electronic health records maps onto the same workflow.
Patient Workflow From Upload to Final Decision
Looking at the patient’s own path, the workflow for an AI appeal tool is simple on paper: upload, review, submit, track. The reality is that each step has deadlines that insurers enforce aggressively. A denied patient usually has 180 days after a plan notice to file an internal appeal. They then have four months after a final internal denial to request external review under ACA rules summarized in the CMS external appeals guide. Missing either deadline waives the right to appeal entirely, so the first job of any AI tool to combat health insurance denials is calendar discipline.
The upload step should include the original denial letter, the plan’s Summary of Benefits and Coverage, and any clinical notes the ordering physician can share. Counterforce and Claimable both guide the patient through this intake with on-screen prompts, while Fight Health Insurance accepts a photo of the denial and lets the user type the rest. Clinical notes from the ordering physician matter most when the denial cites a medical-necessity reason. A good intake also captures whether the plan is a fully insured state plan, an ERISA self-funded plan, or a Medicare Advantage plan. Each of those pathways has a different external reviewer and a different timeline for response.
Review is the stage where patients save themselves from quiet AI mistakes in the draft. The AI draft should read as a human letter, with the correct member number, provider name, and requested service matching the actual case file. Patients should verify that cited studies exist, that the plan language quoted is accurate, and that no patient identifier beyond what the insurer already has is exposed. The letter can then be sent through the plan’s secure portal, by certified mail, or (for Fight Health Insurance users) through its paid faxing option. Patients should keep a dated copy of the submitted packet in case of a dispute.
Tracking matters because insurers occasionally lose or delay appeal responses. Counterforce Health’s “Maxwell” voice agent will call the insurer on the patient’s behalf to confirm receipt, log the case number, and ask for a decision date. Claimable copies key regulators and sometimes journalists when a denial drags, a pressure tactic that PYMNTS reported in 2026 has moved cases faster. If a patient’s internal appeal is denied again, the external-review stage is the last stop before litigation, and most states commit to a 30 or 45 day turnaround. A clinic-facing perspective on how Medicare has started piloting AI prior authorization helps set expectations for Medicare Advantage denials specifically.
External Review and the ACA Safety Net
Stepping back from internal processes, the external review stage is often where AI appeals make the biggest difference. Under the Affordable Care Act, almost every non-grandfathered plan must offer an independent external review once internal appeals are exhausted. The CMS external appeals portal publishes the correct state or federal pathway for each plan type. Independent review organizations overturn denials at meaningfully higher rates than insurers themselves do on second internal review. For patients willing to escalate, the external stage is the single highest-leverage moment in the entire appeal process.
AI tools shine here because the independent reviewers care about evidence and citations, not emotion. Counterforce Health files its external appeals already formatted to reviewer expectations, with clinical guidelines, plan language, and a tight statement of why the denial violated the plan’s own medical-necessity rule. Claimable’s letters copy state insurance regulators, which creates a parallel paper trail that regulators can aggregate when auditing denial patterns across an insurer. This second-order effect, where individual appeals aggregate into regulatory pressure, is new in the AI appeal landscape. Independent review organizations have begun to notice the uptick in better-cited patient filings.
External review has strict deadlines and limits that any AI tool should surface before the patient files. Most states give the reviewer 45 days for standard requests and 72 hours for expedited cases, as laid out in the federal rules on appealing health plan decisions. A well-written AI appeal also names the specific plan provision violated and quotes the plan language. External reviewers find that pattern persuasive, and it aligns with how AI applications across healthcare today are judged. Patients who want to see how this fits into the broader discussion of evolving AI ethics and laws can read our sister primer for context on regulatory pressure.
Insurer AI Versus Patient AI in the Same System
Building on the external review picture, patient-side AI appeal tools are, in effect, a response to insurer-side systems in which AI-driven insurance denials have sparked controversy. UnitedHealth’s nH Predict algorithm faces a class-action suit alleging it generates post-acute care denials with an error rate near 90 percent. Cigna’s PXDX review tool reportedly denied around 300,000 claims in two months at an average of 1.2 seconds per claim. These systems are automated decision platforms built to cut review costs; they are the same technology shape as the patient AI, pointed in the opposite direction. The result is an asymmetrical arms race where insurers automated denial first and patients are now automating rebuttal.
That asymmetry has already produced legal consequences across federal and state courts. ERISA class actions filed in 2024 and 2025 argue automated denials without physician review violate plan terms and federal law, especially when the AI never sees the record. State attorneys general are also opening parallel consumer protection investigations. Bloomberg Law reported that the UnitedHealth and Cigna lawsuits are only the leading edge of what analysts expect will be a broader wave of AI-denial litigation. Patient-side AI appeal letters can cite these suits by name, and some patients use them explicitly as leverage during an appeal.
Insurers are responding both by defending their own automation and, in some cases, by adding human review loops. A balanced reading of the dynamic appears in our CareCode’s AI-driven healthcare innovations explainer, which covers payers and providers building AI with human-in-the-loop defaults. For patients, the practical point is straightforward in day-to-day appeal filing. An AI appeal that names the insurer’s own algorithm and asks for physician review often forces the carrier to escalate the case to a human reviewer sooner. That escalation alone changes the economics of denial for the insurer.
Ethical Lines AI Appeal Tools Must Not Cross
Turning to ethics, the same arms-race logic can push AI appeal tools into territory where they cause harm. The clearest line AI appeal tools must not cross is the fabrication of sources or citations. An AI that invents a clinical study, misquotes a statute, or hallucinates a plan provision will damage the patient’s credibility and may be treated as fraud by the insurer. Melanie Warrick, quoted in Time, told the magazine she would rather these tools stop being necessary than see them replace human advocacy. Our ethical concerns in AI healthcare applications primer stakes out a similar position. Patients and clinicians using AI appeal tools therefore need to verify every cited source before filing. This matters more when the model is a general-purpose LLM rather than a specialist system.
Another ethical line concerns the aggressive escalation pattern that Claimable practices, where appeals copy politicians, regulators, and journalists to pressure the insurer. Some patient advocates argue this crosses from advocacy into coercion when taken too far. The tactic works but can backfire for patients in ongoing care relationships, especially for chronic-disease patients who may need the same insurer for years. Our broader coverage of ethical concerns in AI healthcare applications explains how patient-facing automation should balance leverage against relationship risk. It complements our wider survey of AI applications across healthcare today.
Privacy, HIPAA, and Data Handling Realities
Shifting focus to privacy, every AI appeal tool touches protected health information, which triggers HIPAA. Patients submitting denial letters, provider notes, and plan documents are essentially handing over the most sensitive slice of their record, so data handling matters as much as draft quality. Counterforce Health markets a HIPAA-compliant infrastructure, and Fight Health Insurance uses on-device OCR so the denial letter never leaves the user’s device. Any AI tool that cannot explain in plain English how it stores, encrypts, and deletes patient data should not be trusted with a denial packet. Patients can usually find this detail in a published privacy policy on the vendor site.
Patients should ask three concrete questions of any AI appeal vendor before signing up. First, does the tool run on infrastructure covered by a signed Business Associate Agreement with the cloud provider, as HIPAA requires? Second, is patient data used to train models, and if so, is that training opt-in, opt-out, or impossible to disable? Third, does the service delete records on request, and does the deletion extend to backups? Our overview of patient data privacy in healthcare AI walks through the deeper tradeoffs that come up when answering those three questions.
Even with a careful vendor, patients control the first layer of privacy themselves, and this fits into broader evolving AI ethics and laws dynamics. A denial letter or chart note often contains the member ID, date of birth, and provider identifiers that are not strictly needed for an appeal argument. Patients can redact unnecessary identifiers before upload, especially if the service accepts free-text summaries. The strongest tools automate this redaction, but patients should verify. For patients considering deeper tools with broader data access, a vendor-selection primer such as evaluating AI vendors for healthcare captures the right due-diligence pattern.
Risks, Error Rates, and Hallucination Concerns
Looking at risk, hallucination is the most direct technical failure mode of an AI appeal tool. A large language model may invent a plausible-sounding statute, cite a clinical study that does not exist, or misquote a plan provision in a way that collapses on insurer review. Studies on general-purpose models show hallucination rates that would be unacceptable in a legal filing. Specialist tools like Counterforce Health train on a curated set of real appeals and ground their citations in peer-reviewed literature. A patient filing an unverified AI draft is not using the tool correctly; the verification step is part of the tool.
Error rates on insurer-side AI are the mirror problem that patient tools now have to answer for. UnitedHealth’s nH Predict faces claims of a 90 percent error rate on its Medicare Advantage denials, as cataloged on the industry-wide AI denial litigation record. Our breakdown of how dangers of AI bias and discrimination explains how those failures show up in automated decisions. Patient-side tools should document their own accuracy transparently, including how often their appeals are overturned on first internal review versus how often they require external escalation. Vendors that publish win rates without a denominator or a methodology deserve skeptical reading, and patients can cross-reference claims against our review of FDA regulation of AI health tools.
Measurable Outcomes Patients Are Reporting
Turning to outcomes, patients using these tools report concrete reversals, not just anecdotes. Counterforce Health’s own dashboard reports a 75 percent approval rate on more than ten thousand appeals, which the company publishes on its stats page alongside time-to-appeal metrics. Claimable reports roughly three in four user wins, with specific class-action style wins such as Zepbound coverage reversals documented in PYMNTS reporting. Independent verification is still thin, but patient testimonials align with the vendor-reported ranges. Several state regulators have begun auditing those numbers against submitted appeal records.
Time saved is another measurable outcome that patients can bank on when using AI tools. Counterforce Health reports an average of roughly two minutes from denial upload to drafted appeal, down from the hour or more a hand-written appeal takes. For a chronic-disease patient filing three or four appeals a year, the time savings compound into real quality-of-life gains. Even if the success rate is slightly lower than vendor claims, the mere fact of filing at all raises a patient’s chance of a reversal compared with doing nothing. Filing by itself signals to the insurer that the denial will not go unchallenged.
Clinicians report similar productivity gains across rheumatology, oncology, and endocrinology practices. A Wilmington Health clinical coordinator told local reporters she sees same-day or next-day approvals after switching from manual appeals to Counterforce Health. Our framing article on human support costs rising alongside healthcare AI captures why these productivity gains matter so much in a system where billing teams are chronically understaffed. For patients, the sibling takeaway is a little surprising to many first-time askers. Your clinic may already have an AI appeal tool and has not told you, especially as Medicare rolls out AI prior authorization on the payer side.
Buying the Right AI Appeal Service in 2026
Shifting focus to selection, picking the right AI appeal tool is a budget, condition, and workflow decision. Patients on a Medicare Advantage plan with prior-authorization denials benefit most from tools that know that appeal pathway inside out. Medicare Advantage prior authorization pathways are tightening quickly in 2026. Patients on an ERISA self-funded plan will want a tool that references ERISA case law and the plan’s own Summary Plan Description. Medicaid patients benefit most from tools that handle state-specific coverage appeals.
Price matters, but underestimating the effective-cost gap can hide better deals. A 50 dollar Claimable case may win approval for a 2,000 dollar MRI; a free Counterforce appeal may win approval for a year of biologic therapy. The cost of a tool is trivial next to the expected value of a reversed denial, as long as the tool handles the case type. A patient selecting an AI appeal service should start with the condition and the dollars at stake, not the sticker price of the tool. Any tool whose typical case value exceeds its fee by ten times or more is worth trying first.
Workflow fit is the third screen a patient should run before signing up. Patients who prefer talking to typing should prioritize Counterforce Health’s Maxwell voice agent; patients who prefer hands-off, private submissions should pick Fight Health Insurance with its on-device OCR. For patients in a chronic-care relationship with the same insurer, a tool that balances pressure with professionalism, like Counterforce Health, usually ages better than an aggressive letter-copier model. Our broader read on enhancing AI precision in healthcare decisions maps onto exactly this kind of vendor-selection decision. Family members helping an older relative appeal may prefer a service with voice support.
State Laws Reshaping AI-Driven Utilization Review
Looking at regulation, state laws are reshaping what both sides of the AI denial equation can do. California’s SB 1120, the Physicians Make Decisions Act, took effect on January 1, 2025. It requires any denial, delay, or modification of medically necessary care to be reviewed and signed off by a licensed physician with relevant expertise. The law was authored by Senator Josh Becker and sponsored by the California Medical Association. SB 1120 is now the template bill that state legislators across the country are copying.
Texas, New York, Washington, Illinois, and several other states have introduced similar bills or regulations, each with slightly different thresholds for physician review and audit trails. AI appeal tools benefit directly because physician-review requirements give patients a procedural angle to attack purely automated denials. A letter that invokes SB 1120 for a California plan, or a comparable state statute, forces insurers to show that a human physician actually reviewed the case before refusing it. Clinic billing teams track which state laws apply in each case and feed that detail into the AI tool. Patients in states without such laws can still cite the trend to pressure insurers.
Federal regulators are also moving against automated insurance denials on multiple parallel fronts. CMS has signaled tighter prior authorization rules for Medicare Advantage plans. The Department of Labor has reminded ERISA plan administrators that automated denials without proper documentation may violate plan terms. State attorneys general are investigating insurer AI practices for potential consumer protection violations. Our regulatory primer on evolving AI ethics and laws tracks the federal side of this story in more depth.
Legislation also has second-order effects on which AI appeal vendor a patient should pick. An AI tool that automatically detects the patient’s state and inserts the correct statute into the appeal is strictly more useful than one that produces a generic letter. Counterforce Health and Claimable both claim state-level customization; Fight Health Insurance explicitly says it stores regulator decisions for each state. A patient in a state with new AI utilization-review laws should pick a tool that already updates to them. Our vendor-evaluation primer on evaluating AI vendors for healthcare covers the right due-diligence questions.
Future of AI Advocacy in American Healthcare
Beyond the current wave, AI advocacy will keep expanding as both patients and insurers build more sophisticated systems. Patient-side AI appeal tools are moving from single-letter generation to multi-turn case management. Voice agents call insurers, calendar alerts chase deadlines, and integrated pharmacies reorder medications once approvals land. Our forecast of CareCode’s AI-driven healthcare innovations gives a sense of how fast this agentic layer is forming. The next generation of these tools will likely feel less like a letter writer and more like a case manager that never sleeps.
Regulation is also likely to keep tightening on both sides of the Atlantic coast and inland. Chambers USA and state medical associations expect more than a dozen states to adopt physician-review requirements by the end of 2027. Federal rulemaking on AI in utilization review is likely under both Democratic and Republican administrations. Insurers will respond with their own transparent AI, more human-in-the-loop defaults, and potentially negotiated safe harbors with state regulators. A debate on how public AI debates like a public debate about AI’s role in healthcare get translated into actual rules is already underway.
The ultimate measure will be whether patient AI tools reduce the number of valid denials that go unappealed. Every AI appeal platform exists because of attrition in the appeals funnel, not because insurers are uniquely evil. If even a quarter of currently unappealed denials reach a reviewer because an AI made the paperwork trivial, the balance of power inside American health insurance shifts measurably toward patients. Whether that shift sticks will depend on vendor accuracy, regulator vigilance, and patient willingness to use the tools in the first place. The next three years will show whether patient AI has reached the critical mass needed to change insurer behavior broadly.
Reported reversal rates by AI appeal pathway
Vendor-reported wins compared with the typical baseline when patients file a standard letter or skip the appeal entirely.
Source: Counterforce Health self-report, Claimable via PYMNTS 2026; baseline appeal and attrition metrics from the Commonwealth Fund survey summarized in Time.
Key Insights From Current Data
- A Commonwealth Fund survey covered by Time in November 2026 found only about half of denied adults ever filed an appeal.
- Medical debt tracked denials directly, with the Commonwealth Fund survey covered by Time reporting 43 percent of denied patients took on new debt.
- The Experian State of Claims Report 2026 found that 40 percent of surveyed billing leaders see at least one in ten claims denied. The same survey shows 75 percent of providers saying denials are rising year over year.
- Services not covered was cited by 53 percent of respondents as a top denial driver in the 2026 Experian survey data, overtaking coding errors.
- Counterforce Health reports a 75 percent approval rate on more than 10,000 AI-drafted appeals, a benchmark it publishes on its own stats page alongside time-to-appeal metrics.
- Claimable has raised 10 million dollars, with PYMNTS reporting in 2026 that the platform now supports appeals across 28 conditions and 90 treatments, backed by Mark Cuban.
- California’s SB 1120 took effect on January 1, 2025 and now requires a licensed physician to review and sign off on any medical-necessity denial, delay, or modification.
- Only 9 percent of surveyed providers currently use AI in claims and denials, down from 14 percent in 2025, per the Experian State of Claims Report 2026. Yet 64 percent of those same providers say they plan to invest in AI claims technology soon.
Put together, these numbers describe an insurance system where denials are rising, appeals are rare, and patients are shouldering medical debt that compounds for years after the decision. AI tools to combat health insurance denials are therefore not a luxury upgrade; they are a response to a measurable attrition problem in the appeals funnel. Vendor-reported reversal rates in the 70 to 75 percent range align with what regulators expect well-cited appeals to achieve at external review. New state laws such as SB 1120 give patient AI tools a procedural handhold by requiring physician review of the very decisions these tools are rebutting. The net picture is an arms race, with AI deployed on both sides and the margin of victory still decided by whether an individual patient files at all.
Comparison Table: Leading AI Appeal Tools
The five services below cover the main patient-facing options in the AI denial appeal market in 2026. Each column lists a different vendor across seven comparison dimensions. Patients can skim the table to match a tool to their condition, plan type, and privacy preference. The two for-profit options sit beside two free nonprofit alternatives and one billing-focused dispute service. Together they illustrate the five business models currently shipping products in this category.
| Dimension | Counterforce Health | Claimable | Fight Health Insurance | Billyze | Mediloop |
|---|---|---|---|---|---|
| Pricing model | Free for patients, grant-funded | About 50 dollars per case | Free, optional fax fee | About 79 dollars per report, refunds over 1,000 dollars | About 129 dollars per bill negotiation plus annual plan |
| Best for | Chronic disease patients needing cited appeals | Patients in 28 covered conditions willing to pay | Privacy-first patients submitting themselves | Bill review and billing dispute analysis | Bill negotiation for higher-dollar invoices |
| Data sources cited | Peer-reviewed literature, plan language, state regulator decisions | Insurance law, legal precedents, clinical guidelines | State regulator overturns, published appeals, peer-reviewed research | Billing guidelines and coding rules | Negotiator playbooks and provider contracts |
| Vendor-reported outcome | 75 percent approval rate across 10,000-plus appeals | Roughly three in four patient wins | 10,000-plus appeals generated, no official win rate | Billing-discrepancy detection rate not published | Negotiated discount percentages not published |
| Privacy posture | HIPAA infrastructure, nonprofit funding | HIPAA-grade with for-profit model | On-device OCR plus optional server OCR | Standard HIPAA posture | Standard HIPAA posture |
| External review support | Yes, routes to state and federal reviewers | Yes, copies regulators and media | Yes, through state resources | Focused on bills more than denials | Focused on bills more than denials |
| Voice or agentic features | Maxwell voice agent (beta) | Not published | AI chat and AI assistant connector | Not published | Human negotiator with AI assist |
Real-World Examples of AI Appeals in Practice
Three documented cases show how AI appeal tools performed when patients and clinics actually filed real denials.
Tom Whitehead’s Remicade Denial Reversed by Claimable
Tom Whitehead switched insurers in 2025 and was denied coverage for Remicade, the Crohn’s disease biologic he had used for years. His insurer switched him to a biosimilar that led to two kidney stone episodes and a hospital stay, and his doctor’s appeal was upheld by the carrier. He then filed a new appeal through Claimable, which drafted a cited letter grounded in his plan language and clinical precedent. The denial was reversed within five days, according to reporting from Time, and Claimable charged roughly 50 dollars for the case. One limitation is that his first appeal succeeded only after the earlier physician-led appeal failed, suggesting the legal framing was the lever, not the medicine. The net benefit was a three-month gap in appropriate therapy, closed by one 50-dollar AI letter.
Wilmington Health’s Rheumatology Clinic Scales Appeals With Counterforce
Wilmington Health piloted Counterforce Health in its rheumatology clinic starting in 2025, letting its billing team upload denial letters and generate cited appeals inside a shared workflow. A clinical coordinator told local reporters she regularly sees same-day or next-day approvals after switching from manual letters to the tool, as documented on the Counterforce Wikipedia page. The practice reported higher success rates than the roughly 50 percent reversal rate it had before, with per-appeal preparation time dropping from more than one hour to under ten minutes. The main limitation was that the tool still required a nurse case manager to redact patient identifiers and review the draft before submission. The net productivity gain allowed the practice to appeal more denials rather than triaging the easy ones only.
Patients Reversed CVS Zepbound Denials Through Claimable
Claimable ran a coordinated appeal campaign that deployed its AI to help a cohort of patients challenge Zepbound denials. CVS Health was alleged to have steered those patients toward a rival drug covered under its pharmacy benefit. The platform drafted appeals that cited the plan’s own coverage language and the patients’ clinical records, then copied executives, politicians, and journalists on the filings to escalate pressure. The effort was folded into a class action against CVS Health, as PYMNTS reported in 2026. Many individual reversals landed within two weeks of filing, versus the usual 30 to 60 day cycle for manual appeals. The limitation is that aggressive escalation tactics risk backfiring for patients in long-term care relationships with the same insurer. The net outcome was faster coverage for a weight-management drug and a visible example of AI shaping class-action strategy.
Reading list on fighting health insurance denials
Two books that pair well with an AI appeal tool: context on how the system works and tactics for pushing back on bills.
Never Pay the First Bill: And Other Ways to Fight the Health Care System and Win
Investigative health reporter Marshall Allen’s field guide to fighting denials, negotiating bills, and winning appeals from the patient’s side.
Buy on AmazonAn American Sickness: How Healthcare Became Big Business and How You Can Take It Back
Elisabeth Rosenthal’s reporting on how American health insurance evolved and what patients can do to push back when the claim is denied.
Buy on AmazonAs an Amazon Associate, AIplusInfo earns from qualifying purchases.
In-Depth Case Studies of Reversed Denials
Three AI appeal platforms illustrate how different funding models and founder stories shape the patient advocacy product.
Case Study: Neal K. Shah and the Birth of Counterforce Health
Neal Kumar Shah co-founded Counterforce Health in January 2025 after a brutal personal ordeal with his wife's cancer treatment. Repeated insurance denials piled stress on top of a terminal diagnosis for the family. The problem he set out to solve was that patients and caregivers were losing weeks of care time to denial paperwork. Those are the exact weeks when they have the least capacity to produce it. The solution was a free AI tool that reads a denial letter, pulls plan language and clinical guidelines, and drafts a cited appeal patients can file in minutes. Within months of launch, Counterforce filed thousands of appeals and reported a 75 percent approval rate, with grants from the NIH and the University of Pennsylvania backing the nonprofit model. Shah's team also piloted the tool in rural North Carolina via a mobile outreach clinic named Appeals on Wheels, and the Counterforce Wikipedia article documents the first year of growth.
The measurable impact was significant but came with controversy over vendor-reported numbers. The 75 percent approval rate roughly doubles the typical patient win rate at internal appeal. The average two-minute generation time compares with the hour or more a hand-written letter requires. Local news coverage from WECT described same-day or next-day approvals at Wilmington Health's rheumatology clinic, where Counterforce ran its first real-world pilot. The limitation acknowledged on the company's own site is that marketing figures are vendor-reported and not yet independently audited by state regulators. Counterforce's commitment to never accept insurer funding raises sustainability questions for a nonprofit operating at the scale of American health insurance. Still, the project proved patient-side AI advocacy can scale from a kitchen-table idea to national media coverage within one year.
Case Study: Warris Bokhari and Claimable's For-Profit Advocacy Model
Warris Bokhari co-founded Claimable in 2023 as a physician-led for-profit answer to the same denial problem. The product is aimed at patients who want a faster, more automated letter and are willing to pay. The product challenge was teaching a large language model enough insurance law, plan language, and clinical evidence to produce an appeal that a human attorney would be comfortable signing. Claimable's solution grounded its model in insurance statutes, legal precedents, and a curated clinical corpus, then designed the output to copy regulators, politicians, and journalists for leverage. The company has raised roughly 10 million dollars, including investment from Mark Cuban. It has signed four drug-maker deals to appeal denials on behalf of patients, as PYMNTS reported in 2026. Users pay about 50 dollars per case; vendor-reported win rates sit near three in four appeals.
Claimable's measurable impact includes successful Zepbound coverage reversals as part of a broader class action against CVS Health and a growing litigation arm exploring class-based challenges to automated denials. Supported conditions have grown to 28, with 90 treatments covered. The biggest limitation is business-model related: a per-case fee may limit access for exactly the low-income patients most frequently denied, especially when a denial leads straight to medical debt. Ethicists quoted in Time's November 2026 feature also worry that aggressive media-copying tactics damage long-term patient-insurer relationships. Still, Claimable has demonstrated that AI-powered appeals can scale as a venture-backed service, not only as a nonprofit mission.
Case Study: Holden Karau's Fight Health Insurance Open Model
Holden Karau launched Fight Health Insurance after watching generative models improve to the point where a credible appeal drafter was buildable in early 2024. The problem she tackled was privacy: many patients refuse to upload a denial letter to a cloud service, especially one that might train on patient data. The solution Fight Health Insurance built uses on-device OCR to parse the denial on the user's own phone or computer. It then pulls from a corpus of published state insurance regulator overturns to craft an appeal. The tool is free and offers an optional faxing service for a small fee. It lets users compare multiple drafts in an "Appeal Arena" mode that trains a selector on user votes, per its Appeal Arena documentation.
Measurable impact is harder to pin down than at Counterforce or Claimable. Fight Health Insurance publishes a running total of more than 10,000 appeals generated, though it reports no official win rate percent. Its Denial Watch dashboard reports about one in six (roughly 16 percent) in-network HealthCare.gov claims were denied in 2025. The dashboard aggregates public records into a denial map that regulators now cite. The main limitation is user-submission effort: users must print or fax the letter themselves unless they pay for faxing, which shifts friction back to the patient. Supporters argue the open model, with data staying on-device, is the only ethically sustainable form of a patient AI advocacy service. Fight Health Insurance therefore stands for the privacy-first branch of the AI appeal movement, and its impact is measurable in the thousands of appeals its Appeal Arena has helped draft.
Frequently Asked Questions on AI Tools That Fight Health Insurance Denials
It reads a denial letter and extracts the member details and denial reason. It then drafts a cited appeal that quotes plan language, state regulator decisions, and clinical guidelines. The patient or doctor reviews the draft, files it with the insurer, and the tool often tracks deadlines.
Counterforce Health, Claimable, and Fight Health Insurance lead the patient-facing market in 2026. Counterforce is free and nonprofit, Claimable charges about 50 dollars per case and supports 28 conditions, and Fight Health Insurance is free with on-device OCR. Pick the tool that best fits your medical condition, budget, and privacy preference before uploading.
Counterforce Health and Fight Health Insurance are free for patients. Fight charges a small fax fee only if you use its faxing option. Claimable charges about 50 dollars per case, Billyze about 79 dollars per report, and Mediloop about 129 dollars per bill negotiation plus an annual plan.
No, no AI tool can guarantee reversal, and claims of magic overturn rates deserve skepticism. Vendor-reported win rates in the 70 to 75 percent range align with external reviewer reversal patterns. The strongest predictor is still a specific, well-cited rebuttal filed before the deadline, which AI tools help you produce.
Reputable services run on HIPAA-compliant infrastructure with Business Associate Agreements, and some offer on-device OCR so documents never leave your phone. Patients should still ask whether the service trains models on their data, deletes records on request, and encrypts in transit and at rest. Patients should also redact any unnecessary identifiers from the denial letter before uploading.
Most non-grandfathered plans give patients 180 days from a plan decision to file an internal appeal and four months after a final internal denial to request external review. Expedited reviews involving urgent medical risk must be decided by the insurer within 72 hours. Deadlines vary slightly by state and by Medicare Advantage rules, so confirm in your plan documents.
An independent review organization unaffiliated with your insurer reviews the denial and plan documents, then issues a binding decision. AI appeal tools help by producing citation-heavy letters tuned to reviewer expectations. Counterforce, Claimable, and Fight Health Insurance all support external review filings with the correct state or federal reviewer.
Yes, but the pathway differs by plan type and the tool must know the difference. Medicare Advantage appeals follow CMS rules with their own forms and deadlines, while ERISA self-funded plans add federal fiduciary standards. Counterforce Health and Claimable both claim multi-plan support; confirm your plan type before filing.
Yes, several tools offer clinic-facing dashboards that integrate with billing software. Wilmington Health piloted Counterforce Health's clinic workflow, reporting faster same-day or next-day approvals in rheumatology. Billing teams can triage denials by expected success probability and let the AI pre-draft letters humans then edit.
California's SB 1120 requires a physician to review medical-necessity denials from Jan 1, 2025 onward, and several other states are passing similar laws. Federal ERISA case law treats automated denials without clinical review as potentially bad-faith behavior. AI appeal letters can cite these laws and pending lawsuits to pressure insurers for human review.
The main risks are hallucinated citations, misquoted plan language, and overly aggressive tactics that damage your relationship with the insurer. General-purpose models are more prone to invention than specialist tools trained on real appeals. Always verify cited studies and plan provisions before filing, and prefer tools with transparent accuracy reporting.
No, filed appeals are evaluated on their merits, not their origin. Insurers see citation-heavy letters from attorneys and patient advocates regularly, and AI-drafted appeals look similar. Some advocates recommend keeping tone professional and avoiding the most aggressive escalation tactics if you plan to stay with the same insurer long-term.
Doctors write clinical justifications grounded in medicine and sometimes in frustration. AI appeal tools add plan language citations, state regulator precedents, and formal procedural arguments that insurers must respond to in writing. The strongest appeals pair a doctor's medical argument with an AI-drafted legal and plan-language rebuttal in the same packet.
Contact your state insurance regulator, file a complaint with the National Association of Insurance Commissioners, and consider consulting a healthcare attorney. ERISA plan participants have access to federal court remedies, and class-action attorneys are increasingly tracking AI denial patterns. Nonprofit case managers at Counterforce Health offer free one-on-one support for complex cases.